149 related articles for article (PubMed ID: 37781715)
1. Exploration of the mechanism of aloin ameliorates of combined allergic rhinitis and asthma syndrome based on network pharmacology and experimental validation.
Feng Y; Qiao H; Liu H; Wang J; Tang H
Front Pharmacol; 2023; 14():1218030. PubMed ID: 37781715
[No Abstract] [Full Text] [Related]
2. Network pharmacology and molecular docking to explore the potential mechanism of urolithin A in combined allergic rhinitis and asthma syndrome.
Cong S; Feng Y; Tang H
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2165-2177. PubMed ID: 36961550
[TBL] [Abstract][Full Text] [Related]
3. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
Gao J; Yang S; Xie G; Pan J; Zhu F
Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
[TBL] [Abstract][Full Text] [Related]
4. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
[TBL] [Abstract][Full Text] [Related]
5. Exploring the effect and mechanism of Aloin A against cancer cachexia-induced muscle atrophy via network pharmacology, molecular docking, molecular dynamics and experimental validation.
Dawuti A; Ma L; An X; Guan J; Zhou C; He L; Xu Y; Han B; Abulizi A
Aging (Albany NY); 2023 Dec; 15(24):15557-15577. PubMed ID: 38180061
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of Zixin Biqiu Granules in treatment of allergic rhinitis based on network pharmacology and molecular docking technology].
Yuan AL; Ming Y; Zhang XY; Shu XY
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5344-5352. PubMed ID: 36472042
[TBL] [Abstract][Full Text] [Related]
7. Combined allergic rhinitis and asthma syndrome (CARAS).
Paiva Ferreira LKD; Paiva Ferreira LAM; Monteiro TM; Bezerra GC; Bernardo LR; Piuvezam MR
Int Immunopharmacol; 2019 Sep; 74():105718. PubMed ID: 31255882
[TBL] [Abstract][Full Text] [Related]
8. Correlation between upper and lower airway inflammations in patients with combined allergic rhinitis and asthma syndrome: A comparison of patients initially presenting with allergic rhinitis and those initially presenting with asthma.
Xia S; Zhu Z; Guan WJ; Xie YQ; An JY; Peng T; Chen RC; Zheng JP
Exp Ther Med; 2018 Feb; 15(2):1761-1767. PubMed ID: 29434763
[TBL] [Abstract][Full Text] [Related]
9. Investigating the mechanism of Tongqiao Huoxue decotion in the treatment of allergic rhinitis based on network pharmacology and molecular docking: A review.
Zhang F; Wu J; Shen Q; Chen Z; Qiao Z
Medicine (Baltimore); 2023 Mar; 102(10):e33190. PubMed ID: 36897696
[TBL] [Abstract][Full Text] [Related]
10. miR-21-5p Modulates Airway Inflammation and Epithelial-Mesenchymal Transition Processes in a Mouse Model of Combined Allergic Rhinitis and Asthma Syndrome.
Mao Z; Ding Z; Liu Z; Shi Y; Zhang Q
Int Arch Allergy Immunol; 2024 Apr; ():1-11. PubMed ID: 38588656
[TBL] [Abstract][Full Text] [Related]
11. RNA Sequencing and Bioinformatics Analysis to Reveal Potential Biomarkers in Patients with Combined Allergic Rhinitis and Asthma Syndrome.
Mao ZD; Liu ZG; Qian Y; Shi YJ; Zhou LZ; Zhang Q; Qi CJ
J Inflamm Res; 2023; 16():6211-6225. PubMed ID: 38145010
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with allergic rhinitis and combined allergic rhinitis and asthma syndrome (CARAS) in children aged 5-18 years undergoing immunotherapy in a tropical low- or middle-income country.
Peñaranda A; Gantiva M; Moreno-López S; Peñaranda D; Pérez-Herrera LC; García E
Allergol Immunopathol (Madr); 2023; 51(1):126-132. PubMed ID: 36617831
[TBL] [Abstract][Full Text] [Related]
13. Potent ameliorating effect of Hypoxia-inducible factor 1α (HIF-1α) antagonist YC-1 on combined allergic rhinitis and asthma syndrome (CARAS) in Rats.
Wang X; Liu C; Wu L; Zhu S
Eur J Pharmacol; 2016 Oct; 788():343-350. PubMed ID: 27498367
[TBL] [Abstract][Full Text] [Related]
14. Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP.
Li HT; Chen ZG; Liu H; Ye J; Zou XL; Wang YH; Yang HL; Meng P; Zhang TT
Exp Lung Res; 2016 Aug; 42(6):322-33. PubMed ID: 27541375
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology-based study of the protective mechanism of conciliatory anti-allergic decoction on asthma.
Xuan X; Sun Z; Yu C; Chen J; Chen M; Wang Q; Li L
Allergol Immunopathol (Madr); 2020; 48(5):441-449. PubMed ID: 32359824
[TBL] [Abstract][Full Text] [Related]
16. PM2.5 exposure regulates Th1/Th2/Th17 cytokine production through NF-κB signaling in combined allergic rhinitis and asthma syndrome.
Piao CH; Fan Y; Nguyen TV; Song CH; Kim HT; Chai OH
Int Immunopharmacol; 2023 Jun; 119():110254. PubMed ID: 37163921
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology and experimental evidence: MAPK signaling pathway is involved in the anti-asthma roles of
Cao M; Zhan M; Jing H; Wang Z; Wang Y; Li X; Miao M
Heliyon; 2024 Jan; 10(1):e22971. PubMed ID: 38163225
[No Abstract] [Full Text] [Related]
18. CpG-ODNs and Budesonide Act Synergistically to Improve Allergic Responses in Combined Allergic Rhinitis and Asthma Syndrome Induced by Chronic Exposure to Ovalbumin by Modulating the TSLP-DC-OX40L Axis.
Li HT; Chen ZG; Lin YS; Liu H; Ye J; Zou XL; Wang YH; Yang HL; Zhang TT
Inflammation; 2018 Aug; 41(4):1304-1320. PubMed ID: 29654433
[TBL] [Abstract][Full Text] [Related]
19. Bergapten ameliorates combined allergic rhinitis and asthma syndrome after PM2.5 exposure by balancing Treg/Th17 expression and suppressing STAT3 and MAPK activation in a mouse model.
Jiang Y; Nguyen TV; Jin J; Yu ZN; Song CH; Chai OH
Biomed Pharmacother; 2023 Aug; 164():114959. PubMed ID: 37267637
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with allergic rhinitis and combined allergic rhinitis and asthma syndrome (CARAS) in adults undergoing immunotherapy in a tropical country: Is ISAAC-III questionnaire useful in adult populations?
Peñaranda A; Pérez-Herrera LC; Gantiva M; Moreno-López S; Manrique J; Peñaranda D; García E
Allergol Immunopathol (Madr); 2023; 51(4):78-86. PubMed ID: 37422783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
